Small methods · 2026
Domains Dictate Antibody Adsorption Architectures at Biocompatible Interfaces: Elucidation by QCM-D and Neutron Reflectometry.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shen Kangcheng, Liao Mingrui, Hu Xuzhi, Li Peixun, Allgaier Jürgen, Kalonia Cavan, Lu Jian Ren
Аннотация
The interfacial stability of therapeutic monoclonal antibodies (mAbs) remains a critical challenge in pharmaceutical development, particularly in the context of biocompatible silicone oil-coated delivery devices. Here, we present a molecular-level investigation of antibody conformational dynamics at model polydimethylsiloxane (PDMS) interfaces under varying pH conditions. Using a multi-technique approach combining neutron reflection (NR), spectroscopic ellipsometry (SE), and quartz crystal microbalance with dissipation (QCM-D), the pH-dependent structural adaptations of two engineered antibodies, COE-3 and COE-7, and their constituent Fab and Fc fragments were revealed. Both COE-3 and COE-7 underwent distinct conformational transitions between pH 5.5 and 8.0, with a remarkable shift from monolayer to bilayer architectures. At pH 5.5, both antibodies formed compressed monolayers, indicating substantial molecular deformation. As pH approached the isoelectric point (pH 8.0), a unique bilayer architecture emerged, with a densely packed inner layer supporting a more diffuse and non-deformed outer layer. Notably, this pH-induced structural reorganization was primarily driven by the Fc region, while the Fab fragments maintained consistent monolayer conformations regardless of pH conditions. Our work has established a quantitative framework for illustrating antibody-surface interactions and the contribution of individual fragments in the adsorption process. This mechanistic understanding opens new avenues for enhancing the stability of antibody-based pharmaceuticals on silicone oil-coated delivery devices.